After years of weight loss drug shortages, the FDA is saying there's now an adequate supply for most medications and they ...
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...
Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity ...
The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...
Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Amy Schumer endorses the new weight loss drug Mounjaro, praising its effectiveness after an adverse experience with Wegovy.
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
The FBI says counterfeit versions of the drugs can cause ... using any medications for weight loss. Legitimate versions of compound drugs are copies of FDA-approved medications made by licensed ...
As a busy mom of three who had tried other weight loss drugs ... has allowed her “a new level of freedom.” However, with impending FDA changes around compounded drugs, it could all be taken ...